How Does the Patient Benefit from Clinical PET?
Clinical molecular imaging by use of PET and PET/CT is increasingly important in routine oncological practice worldwide. A vast majority of clinical PET investigations are performed with [18F]-fluorodeoxyglucose (FDG), but there is a growing interest in novel molecular probes among scientists and cl...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Ivyspring International Publisher
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360196/ |